title: Relationship between plasma adrenomedullin levels and metabolic control, risk factors, and diabetic microangiopathy in patients with type 2 diabetes.
authors.forename: H M
authors.initials: HM
authors.lastname: Turk
authors.forename: S
authors.initials: S
authors.lastname: Buyukberber
authors.forename: A
authors.initials: A
authors.lastname: Sevinc
authors.forename: G
authors.initials: G
authors.lastname: Ak
authors.forename: M
authors.initials: M
authors.lastname: Ates
authors.forename: R
authors.initials: R
authors.lastname: Sari
authors.forename: H
authors.initials: H
authors.lastname: Savli
authors.forename: A
authors.initials: A
authors.lastname: Cigli
mesh_terms: D053607:Adrenomedullin; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000097:blood* / Q000503:physiopathology* / Q000628:therapy; D003927:Diet, Diabetic; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood; D006973:Hypertension / Q000097:blood; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010455:Peptides / Q000097:blood*; D012307:Risk Factors
chemical_list: D053607:Adrenomedullin; D015415:Biomarkers; D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D010455:Peptides